Compare Hims and Hers Health Inc (HIMS) vs Kraft Heinz Co (KHC) Price & Performance

Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.

The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.

Kraft Heinz (KHC) trades at $21.98, down 0.23% on the day, with a bearish technical signal and mixed fundamentals. Recent earnings have beaten estimates, but 2025 saw a net loss of $5.85 billion due to impairment charges, though operating cash flow remains strong at $4.46 billion. The company is executing a turnaround strategy, including a $700 million reinvestment and new product launches like Philadelphia cream cheese flavors, to revive brand relevance amid volume challenges.

The stock offers a discounted valuation with a P/E of 13.04 and P/B of 0.72, but high debt and negative ROE pose risks. Analyst consensus is cautious with a hold-heavy rating and $23.78 price target, implying modest upside. Key opportunities include cash flow stability and brand reinvestment, while risks involve persistent volume declines and competitive pressures in the consumer goods sector.